Risk of relapse to non-opioid addictive substances among opioid dependent patients treated with an opioid receptor antagonist or a partial agonist: A randomized clinical trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk of relapse to non-opioid addictive substances among opioid dependent patients treated with an opioid receptor antagonist or a partial agonist: A randomized clinical trial

Published:2023-12 Issue: Volume:135 Page:107360
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Opheim Arild,Benth Jūratė Šaltytė,Solli Kristin Klemmetsby,Kloster Pia S.,Fadnes Lars Thore,Kunøe Nikolaj,Gaulen Zhanna,Tanum Lars

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference25 articles.

1. Opioid challenge evaluation of blockade by extended-release naltrexone in opioid-abusing adults: dose–effects and time-course;Bigelow;Drug Alcohol Depend.,2012

2. ‘Not at all what I had expected’: Discontinuing treatment with extended-release naltrexone (XR-NTX): A qualitative study;Brenna,2021

3. Drop-out from addiction treatment: A systematic review of risk factors;Brorson;Clin. Psychol. Rev.,2013

4. Transition of patients with opioid use disorder from Buprenorphine to extended-release naltrexone: a randomized clinical trial assessing two transition regimens;Comer,2020

5. Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial;Comer;Arch. Gen. Psychiatry,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP